Thad Cochran bought Zoetis Inc (NYSE: ZTS)
Thad Cochran (R-MS), a U.S. Senator, has disclosed 1 trade in Zoetis Inc (ZTS) since 2017, a single purchase, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Thad Cochran bought $15,001 - $50,000 of Zoetis Inc (NYSE: ZTS) on June 13, 2017. Since that trade, ZTS is up +35.32% against the S&P 500 up +244.00%, an outperformance of -208.68%.
Data updated
Thad Cochran's ZTS trades vs the price
ZTS is up +35.32% since Thad Cochran bought on June 13, 2017, versus +244.00% for the S&P 500.
Performance since this trade
All Thad Cochran ZTS trades
Thad Cochran & ZTS trading FAQ
Is it legal for Thad Cochran to trade Zoetis Inc (ZTS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Zoetis Inc (ZTS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Thad Cochran buy ZTS?
Thad Cochran disclosed a purchase of $15,001 - $50,000 of Zoetis Inc (ZTS) on June 13, 2017, according to public STOCK Act filings.
How has ZTS performed since Thad Cochran's trade?
Since Thad Cochran bought ZTS on June 13, 2017, the stock is up +35.32%, versus +244.00% for the S&P 500 over the same period, an outperformance of -208.68%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ZTS trades?
Quantellect tracks every disclosed congressional trade in Zoetis Inc (ZTS) on the Zoetis Inc congressional trading page, which aggregates filings across all members of Congress.
Thad Cochran's ZTS tradesAll congressional filings for Zoetis IncThad Cochran's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.